These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 558623)

  • 41. Effects of delta9-THC on food and water intake of deprivation experienced rats.
    Gluck JP; Ferraro DP
    Behav Biol; 1974 Jul; 11(3):395-401. PubMed ID: 4413126
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of delta9-tetrahydrocannabinol on quinine palatability and AM251 on sucrose and quinine palatability using the taste reactivity test.
    Jarrett MM; Scantlebury J; Parker LA
    Physiol Behav; 2007 Feb; 90(2-3):425-30. PubMed ID: 17118412
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
    Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The uptake of delta9-tetrahydrocannabinol in choroid plexus and brain cortex in vitro and in vivo.
    Agnew WF; Rumbaugh CL; Cheng JT
    Brain Res; 1976 Jun; 109(2):355-66. PubMed ID: 1276919
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of repeated juvenile exposure to Δ9‑tetrahydrocannabinol on anxiety-related behavior and social interactions in adolescent rats.
    Mohammed AN; Alugubelly N; Kaplan BL; Carr RL
    Neurotoxicol Teratol; 2018; 69():11-20. PubMed ID: 29936119
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Penetration of delta-9-tetrahydrocannabinol and 11-OH-delta-9-tetrahydrocannabinol through the blood-brain barrier.
    Schou J; Prockop LD; Dahlstrom G; Rohde C
    Acta Pharmacol Toxicol (Copenh); 1977 Jul; 41(1):33-8. PubMed ID: 578377
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distribution of Synthetic Cannabinoids JWH-210, RCS-4 and Δ 9-Tetrahydrocannabinol After Intravenous Administration to Pigs.
    Schaefer N; Kettner M; Laschke MW; Schlote J; Ewald AH; Menger MD; Maurer HH; Schmidt PH
    Curr Neuropharmacol; 2017; 15(5):713-723. PubMed ID: 27834143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of hippocampal acetylcholine release after acute and repeated Delta9-tetrahydrocannabinol in rats.
    Carta G; Nava F; Gessa GL
    Brain Res; 1998 Oct; 809(1):1-4. PubMed ID: 9795096
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tolerance development to the effect of delta9-tetrahydrocannabinol on conditioned behavior: role of treatment interval and influence of microsomal metabolism.
    Davis WM; Borgen LA
    Arch Int Pharmacodyn Ther; 1975 Jan; 213(1):97-112. PubMed ID: 1156021
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gender differences in proenkephalin gene expression response to delta9-tetrahydrocannabinol in the hypothalamus of the rat.
    Corchero J; Fuentes JA; Manzanares J
    J Psychopharmacol; 2002 Dec; 16(4):283-9. PubMed ID: 12503826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Precoital single doses of delta9-tetrahydrocannabinol block ovulation in the rabbit.
    Asch RH; Fernandez EO; Smith CG; Pauerstein CJ
    Fertil Steril; 1979 Mar; 31(3):331-4. PubMed ID: 374129
    [TBL] [Abstract][Full Text] [Related]  

  • 52. delta9-Tetrahydrocannabinol: tolerance after noncontingent exposure in rats.
    Järbe TU
    Arch Int Pharmacodyn Ther; 1978 Jan; 231(1):49-56. PubMed ID: 637625
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies on the metabolism of the Delta9-tetrahydrocannabinol precursor Delta9-tetrahydrocannabinolic acid A (Delta9-THCA-A) in rat using LC-MS/MS, LC-QTOF MS and GC-MS techniques.
    Jung J; Meyer MR; Maurer HH; Neusüss C; Weinmann W; Auwärter V
    J Mass Spectrom; 2009 Oct; 44(10):1423-33. PubMed ID: 19728318
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of delta9-tetrahydrocannabinol on phosphorylated CREB in rat cerebellum: an immunohistochemical study.
    Casu MA; Pisu C; Sanna A; Tambaro S; Spada GP; Mongeau R; Pani L
    Brain Res; 2005 Jun; 1048(1-2):41-7. PubMed ID: 15913574
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antagonism of the effects on thermoregulation of delta9-tetrahydrocannabinol by clomipramine in the rat.
    Fennessy MR; Taylor DA
    Br J Pharmacol; 1978 Jun; 63(2):267-73. PubMed ID: 667419
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Simultaneous analysis of the Delta9-THC metabolites 11-nor-9-carboxy-Delta9-THC and 11-hydroxy-Delta9-THC in meconium by GC-MS.
    Coles R; Clements TT; Nelson GJ; McMillin GA; Urry FM
    J Anal Toxicol; 2005 Sep; 29(6):522-7. PubMed ID: 16168173
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Δ9-tetrahydrocannabinol (Δ9-THC) administration after neonatal exposure to phencyclidine potentiates schizophrenia-related behavioral phenotypes in mice.
    Rodríguez G; Neugebauer NM; Yao KL; Meltzer HY; Csernansky JG; Dong H
    Pharmacol Biochem Behav; 2017 Aug; 159():6-11. PubMed ID: 28648819
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cortical 3 alpha-hydroxy-5 alpha-pregnan-20-one levels after acute administration of Delta 9-tetrahydrocannabinol, cocaine and morphine.
    Grobin AC; VanDoren MJ; Porrino LJ; Morrow AL
    Psychopharmacology (Berl); 2005 May; 179(3):544-50. PubMed ID: 15619118
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reversal of cannabinoids (delta9-THC) by the benzoflavone moiety from methanol extract of Passiflora incarnata Linneaus in mice: a possible therapy for cannabinoid addiction.
    Dhawan K; Kumar S; Sharma A
    J Pharm Pharmacol; 2002 Jun; 54(6):875-81. PubMed ID: 12079005
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interactions between phencyclidine and delta 9-tetrahydrocannabinol in mice following smoke exposure.
    Freeman AS; Martin BR
    Life Sci; 1983 Mar; 32(10):1081-9. PubMed ID: 6298542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.